Details for New Drug Application (NDA): 211185
✉ Email this page to a colleague
The generic ingredient in CARFILZOMIB is carfilzomib. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carfilzomib profile page.
Summary for 211185
Tradename: | CARFILZOMIB |
Applicant: | Apotex |
Ingredient: | carfilzomib |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 30MG/VIAL | ||||
Approval Date: | Mar 20, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription